Company Filing History:
Years Active: 2025
Title: Le'en Liao: Innovator in Colorectal Cancer Immunotherapy
Introduction
Le'en Liao is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of cancer research, particularly in the area of immunotherapy for colorectal cancer. His innovative work aims to enhance the efficacy of treatments for patients suffering from this challenging disease.
Latest Patents
Le'en Liao holds a patent for a "System for predicting immunotherapeutic efficacy for colorectal cancer." This system performs several critical operations, including obtaining a digital image of biological tissue from a colorectal cancer patient. It predicts tissue type and cell type parameters using a classifier algorithm model. Additionally, it determines various cell feature parameters based on a calculating rule and calculates a therapeutic efficacy score. This score is designed to predict the therapeutic efficacy of immunotherapy for colorectal cancer patients.
Career Highlights
Le'en Liao is affiliated with the Sun Yat-sen University Cancer Center, where he conducts his research and development work. His dedication to improving cancer treatment outcomes has positioned him as a key figure in the field of oncology.
Collaborations
Le'en Liao collaborates with esteemed colleagues, including Peirong Ding and Wu Jiang. Their combined expertise contributes to advancing research in cancer therapies and improving patient care.
Conclusion
Le'en Liao's innovative contributions to colorectal cancer immunotherapy exemplify the potential of technology in enhancing treatment efficacy. His work continues to inspire advancements in cancer research and patient outcomes.